United Therapeutics Corp. said it has received Food and Drug Administration approval for an implantable pump for Remodulin, its flagship pulmonary arterial hypertension drug.
{iframe}https://www.bizjournals.com/washington/news/2018/07/31/united-therapeutics-gets-crucial-green-light-for.html?ana=e_me_set1&s=newsletter&ed=2018-08-01&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1533562594&j=83024331{/iframe}